1) Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 21 (4) : 637-676, 1990.
2) Adams HP Jr, et al. : Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1) : 35-41, 1993.
3) 水野美邦ほか : 慢性期脳血管障害の治療. 神経内科ハンドブック 第4版. pp. 573-577, 医学書院, 2010.
4) 篠原幸人ほか : 脳梗塞再発予防. 脳卒中治療ガイドライン 2009. pp. 85-90, 協和企画, 2009
5) 日本高血圧学会高血圧治療ガイドライン作成委員会編 : 臓器障害を合併する高血圧. 高血圧治療ガイドライン 2009. pp. 46-49, ライフサイエンス出版, 2009.
6) Verdecchia P, et al. : Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertensin 46 (2) : 386-392, 2005.
7) Turnbull F, et al. : Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens 25 (5) : 951-958, 2007.
8) Rothwell PM, et al. : Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 34 (11) : 2583-2590, 2003.
9) Wilcox R, et al. : Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke, results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04). Stroke 38 (3) : 865-873, 2007.
10) 日本糖尿病学会編 : 治療目標とコントロール指標. 治療方針の立て方. 糖尿病治療ガイド 2012-2013 血糖コントロール目標改訂版. pp. 24-30, 文光堂, 2013.
11) Bhatt DL, et al. : Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol 90 (6) : 625-628, 2002.
12) Shinohara Y, et al. Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study. Cerebrovasc Dis 26 (1) : 63-70, 2008.
13) Amarenco P, et al. : High-Dose Atorvastatin after Stroke or Transient Ischemic Attack. N Engl J Med 355 (6) : 549-559, 2006.
14) Tanaka K, et al. : Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients : subanalysis of the JELIS trial. Stroke 39 (7) : 2052-2058, 2008.
15) 日本動脈硬化学会編 : 動脈硬化性疾患予防ガイドライン 2012年版. 日本動脈硬化学会, 2012.